The Challenges Brought by a Cooling Housing Market

With the hot housing market that erupted during COVID-19, experts are starting to say we are “cooling off’ and trending toward a housing recession, reported Michael Bergin, Co-Founder, and VP of Platform at Higharc, a platform for home building design, construction, and sales.

Housing market analyzer and owner of Zelman & Associates Ivy Zelman predicted the 2008 housing market crash. The truth of her prediction may lend accuracy to her forecast for the impending market. Ivy Zelman is calling for a drop in sales price of five percent in 2023 and another five percent in 2024. The National Association of Realtors states the “Latest Housing Indicator” for the median home price is $403,800.

This means a return to a buyer’s market, and it’s been a really long time,” stated Bergin.

Why is this a potential problem? There is still a housing shortage. While more than one million homes were built the last year, only eight of the past 65 years have seen less than 600,000 homes built. This 400,000 difference in the least productive years is small when comparing the relative demand. NPR dove into the issue, stating that there are 3.8 million shortages in housing units in the U.S.

And that projected shortage may not even be accurate. “Demand for new homes has increased so massively since 2020 that it’s hard to tell how many buyers are still out there who have been saving and waiting the whole time,” Bergin explained.

New communities are selling out before the sales center is even open, which is a stark contrast to the situation just a few years ago. How has this impacted customization?

Bergin said, “Buyers had expected a level of customization, they’ve become accustomed to this. Now we’ve seen at the peak of the market, builders pulling back on those customizations and making it so that it’s easier for them to anticipate when the home is going to be built and when it’s going to be ready because there’s less variability, less flexibility”. With the cooldown that is starting to reverse again—there is a pushback toward buyers who want customization.

However, some builders are starting to hurt—especially those on the higher end. For example, Toll Brothers experienced a 60 percent decline in purchase contracts year-over-year. Homebuilders are beginning to look to technology to secure sales because there are fewer qualified buyers on market.

Whether Zelman’s prediction comes to fruition or not, Bergin knows the housing market will experience some drastic changes in the next few years.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More